Pinnacle Associates’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$248K Sell
469
-171
-27% -$78.9K ﹤0.01% 865
2026
Q1
$307K Sell
640
-415
-39% -$212K ﹤0.01% 790
2025
Q4
$593K Buy
+1,055
New +$599K 0.01% 616

Other funds holding MEDP

Pinnacle Associates's MEDP Position: Q2 2026 in Review

Pinnacle Associates reduced its Medpace (MEDP) stake by 27% in Q2 2026, selling an estimated $78.9K and leaving 469 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #865.

Pinnacle Associates first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. The position peaked at $593K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Pinnacle Associates held 469 shares of Medpace worth $248K as of Q2 2026.
  • Pinnacle Associates sold 171 Medpace shares in Q2 2026, an estimated $78.9K.
  • Medpace made up ﹤0.01% of Pinnacle Associates's portfolio in Q2 2026, its #865 holding.
  • Pinnacle Associates first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
  • Pinnacle Associates's Medpace position peaked at $593K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Pinnacle Associates's 13F filing for Q2 2026, filed 3 Aug 2026.